Having trouble viewing this email? Click here
Image

WHAT'S NEW

BÜHLMANN CALEX® Cap News

Image

BÜHLMANN CALEX® Cap, a single use tube intended for the preparation of human stool samples to be used with the BÜHLMANN fCAL® turbo, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US.

LEARN MORE

CALEX® Cap Tutorial

Image

View this tutorial and learn how the CALEX® Cap stool extraction device offers an efficient, convenient and hygienic extraction of stool samples and is fully compatible with total laboratory automation (TLA) solutions.

WATCH VIDEO

IBDoc® News

Image

View these six new IBDoc® Portal Tutorial Videos. They are designed to help Healthcare Professionals that start using IBDoc® with the first steps of creating an account and setting up new users.

( US: IBDoc ® is not available for sale. Canada: Health Canada Licence: 98903, Device class: 3)
LEARN MORE

BÜHLMANN fCAL® turbo News

Image

Read this perspective article pertaining to Freeman Hospital's experience and the benefits they discovered in switching their routine calprotectin testing to BÜHLMANN fCAL® turbo. Learn how this laboratory team could streamline their workflow using the BÜHLMANN fCAL® turbo and CALEX® Cap while also achieving precise, reliable results.

LEARN MORE

TECHNICAL NEWS

 
Image

View the videos from the BÜHLMANN Educational Workshop at EuroMedLab 2019, focused on optimizing workflow for fecal calprotectin testing. Insightful presentations from three laboratories discussing the process of stool sample pre-analytics and how each lab worked to find a solution to cope with continuously increasing test numbers.

MORE INFO

RESOURCES AND RESEARCH

Citations

BUHLMANN fCAL® ELISA:

  • Berinstein, J. et al. The Clinical Accuracy of the BÜHLMANN fCAL® ELISA in the Differentiation of Inflammatory Bowel Disease from Irritable Bowel Syndrome: A Multi-Center Prospective Case-Control Study. Crohn's & Colitis 360 (2019).

IBDoc®:

  • UEGW 2019 Poster (October 19-23): P1074, E. Orfanoudaki et al., Greece.
  • McCombie, A., Walmsey, R. et al. A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases, October 2019.

BÜHLMANN Quantum Blue® TDM:

  • UEGW 2019 (October 19-23): P1750, G. Bodini et al., Italy.

BÜHLMANN HIGHLIGHTS

 
Image

BÜHLMANN CALEX® Cap is a fecal extraction device that offers an efficient, convenient and hygienic stool extraction. Its unique design makes CALEX® Cap compatible with Total Laboratory Automation (TLA) solutions, minimizing the complexity of sample processing thus significantly reducing hands-on time.

 

Combined with BÜHLMANN fCAL®turbo, CALEX® Cap revolutionizes calprotectin pre-analytics and enables workflow optimization through full automation. CALEX® Cap fecal extraction device is the first and only stool extraction device suitable for safe air and land transportation according to IATA 650 (UN3373) regulations.

READ MORE

PROMOTIONS

Image

Combined with BÜHLMANN fCAL® turbo, CALEX® Cap revolutionizes calprotectin pre-analytics and enables workflow optimization through full automation. Learn more about this extraction device and find out the details of our promotion today!

LEARN MORE

BUHLMANN DIAGNOSTICS CORP

 

BÜHLMANN is unique, independent, and reliable in every aspect of its business from the outstanding quality of its products, excellent after-sales services, and remarkable scientific innovations. The establishment of BDC is a statement of the importance of you, our customers and our commitment to understanding your needs. Our North American affiliate will help us to continue to foster closer relationships with our customers and enhance our customer support interactions as well as meet your requirements for future BÜHLMANN products. Quality is not just a statement, but part of our daily mission.

 

105 Route 101A, Suite 1,
Amherst, NH 03031 USA

Ph: (844) 300-9799
info@buhlmannlabs.com
www.buhlmannlabs.com

LEARN MORE
LinkedIn Facebook Twitter